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Figure 1. Regulatory Splicing of Pre-mRNA
in the Platelet Cytoplasm
Platelets are formed by budding of cyto-
plasm from megakaryocytes in the bone
marrow. Although the splicing machinery is
localized in the nucleus of megakaryocyte
precursor cells, splicing factors begin to ac-
cumulate in the cytoplasm of mature mega-
karyocytes. The splicing components together
with specific partially spliced pre-mRNAs are
included in the forming anucleate platelets.
Upon stimulation of platelets, the splicing
machinery is activated and completes the
splicing reaction, giving rise to a translatable
mRNA. In this way, cytoplasmic splicing acts
as a regulatory mechanism during platelet
activation.
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The most provocative question, however, is whether
pre-mRNA splicing in the cytoplasm is limited to plate-
lets or whether it might also act on at least some tran-
scripts in cell types that contain a nucleus. Although
the levels of splicing factors are generally low in the
cytoplasm of most cell types, one should keep in mind
that all proteinaceous splicing factors are synthesized
in the cytoplasm and that snRNPs are assembled there.
If some pre-mRNAs are exported from the nucleus,
these splicing components could act in the same was
as they do in platelets and support cytoplasmic, regula-
tory splicing. Although there are no other known exam-
ples of splicing in the cytoplasm, not to mention the
regulatory function of this process, it is noteworthy that
outgrowth of neuronal axons shares many hallmarks
characteristic of proplatelet morphogenesis and in-
volves spatially localized posttranscriptional RNA regu-
lation. Admittedly, this is a highly speculative scenario,
but in the light of the new work by Denis et al. (2005),
we have no choice but to realize that when it comes to
splicing, the unexpected must always be expected.
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Nicastrin: Gatekeeper
of the -Secretase Complex
The -secretase intramembrane protease cleaves many
type I membrane proteins including amyloid precur-
sor protein and Notch, generating peptide fragments
that are important signaling components. In this is-
sue of Cell, Shah et al. (2005) reveal the function of
nicastrin, the largest member of the -secretase com-
plex. They show that the nicastrin extracellular do-
main is essential for recognition of substrate by the
-secretase.
The enzyme γ-secretase is an intramembrane protease
that cleaves amyloid precursor protein (APP), resulting
in the release of amyloid-β peptide, a principal compo-
nent of the plaques found in the brains of Alzheimer’s
disease patients (Haass and Selkoe, 1993). This prote-
ase, which exists as a protein complex, also cleaves at
least 30 other type I membrane proteins including Notch,
a key signaling component during embryonic develop-
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319ment. The regulated intramembrane proteolysis (RIP) of
integral membrane protein substrates by γ-secretase
and other intramembrane proteases results in the re-
lease of peptide fragments that are important in signal
transduction. The main constituents of the γ-secretase
complex are presenilin, aph-1, pen-2, and nicastrin
(De Strooper, 2003). In this issue of Cell, Shah et al.
(2005) reveal the function of the largest member of
the γ-secretase complex, nicastrin. Using the purified
γ-secretase complex and elegant in vivo reconstitution
assays, these investigators convincingly demonstrate
that the extracellular domain of nicastrin is essential for
substrate recognition by the γ-secretase complex.
Many integral membrane proteins, including recep-
tors and membrane bound growth factors such as
transforming growth factor α (TGFα), shed their ectodo-
mains prior to cleavage by intramembrane proteases.
For example, γ-secretase only cleaves APP after the
bulk of the APP ectodomain has been removed by α-
or β-secretase (for a review see Annaert and De
Strooper [2002]). The shed protein ectodomains exert
a multitude of biological activities that sometimes act
remotely from the location where they originated. Shed-
ding is performed by a wide variety of membrane
bound proteolytic enzymes (“sheddases”) such as
those of the ADAM (a disintegrin and metalloproteases)
family. Obviously, shedding leaves behind the mem-
brane bound anchor of the protein, and the fate of
these hydrophobic protein stubs has been a puzzle.
γ-secretase cleaves these stubs in the transmembrane
domain with an extremely relaxed specificity (a hy-
drophobic α helix seems all that is required). Surpris-
ingly, it is the size of the ectodomain that determines
whether a type I membrane protein becomes a sub-
strate for γ-secretase. Bulky ectodomains of 200 to 300
amino acid residues prevent γ-secretase cleavage,
whereas proteins with ectodomains smaller than about
50 amino acid residues are efficiently cleaved (Struhl
and Adachi, 2000). Thus, a major biological function of
γ-secretase is the clearance of membrane anchors of
shed type I membrane proteins (Schenk, 2000, Kopan
and Ilagan, 2004). This work also implies that γ-secre-
tase is able to measure the length of the ectodomain,
an unexpected property for a protease.
Although clearance of membrane bound stubs is
clearly an important function of γ-secretase, a particular
subspecialization of this protease has generated much
interest. In some cases, γ-secretase is capable of medi-
ating signal transduction through RIP (Brown et al.,
2000) as illustrated by the Notch signaling pathway.
Following binding of its ligand (Delta or Serrate), Notch
becomes cleaved by an ADAM sheddase. The remain-
ing Notch fragment (which has a short ectodomain)
anchors a very large intracellular domain to the cell
membrane. This intracellular domain is released by
γ-secretase cleavage and moves to the nucleus where,
in concert with other transcription factors, it regulates
gene expression (Kopan and Ilagan, 2004). Accordingly,
genetic knockdown of γ-secretase in mice, flies, and
other species causes very specific alterations during
embryogenesis, which are indicative of a defect in
Notch signaling and provide unequivocal evidence thatγ-secretase is an important player in this pathway. In-
terestingly, the cytoplasmic domains of many other
membrane bound substrates such as cadherins, syn-
decans, or the p75 neurotrophin receptor, may become
signaling molecules when cleaved by γ-secretase.
However, deciphering the biological significance of RIP
for these other γ-secretase substrates remains the sub-
ject of intense research.
In this context, the question of how γ-secretase is
able to discriminate between full-length integral mem-
brane proteins (that should not be cleaved) and their
transmembrane stubs generated by the shedding pro-
cess (that need to be removed from the membrane) is
compelling. In their new study, Shah, Yu and their col-
laborators (Shah et al., 2005) provide unequivocal evi-
dence that access to the razorblade of γ-secretase is
controlled by the nicastrin component of the complex.
The extracellular domain of nicastrin binds specifically
to the amino terminal residue of membrane bound pro-
tein fragments generated by sheddases and is then
able to position the bound substrates so as to facilitate
their cleavage by the catalytic presenilin subunit in the
γ-secretase complex. The extracellular binding domain
of nicastrin is reminiscent of aminopeptidase struc-
tures, and the carboxyl function of a particular gluta-
mate residue (E333) in this region is crucial for the bind-
ing interaction. This domain also encompasses a
stretch of amino acid residues (DYIGS) that was pre-
viously shown by Yu et al. (2000) to modulate APP pro-
cessing. They called the substrate binding domain in
nicastrin the DAP domain (DYIGS and peptidase ho-
mologous region).
The evidence that nicastrin is indeed the gatekeeper
of the γ-secretase complex limiting access to the prote-
ase’s catalytic activity is overwhelming. Shah et al.
(2005) demonstrate that nicastrin binds to both APP
and Notch substrates in stoichiometric quantities and
that the interaction can be blocked by antibodies to the
amino terminus, but not to the carboxyl terminus, of the
substrate. They also show that small chemical modifi-
cations to the amino acids at the amino terminus of the
substrate interfere with nicastrin binding and cleavage
by γ-secretase and that an artificially generated nic-
astrin ectodomain when added to a cell-free assay can
block γ-secretase activity. Furthermore, various muta-
tions in the nicastrin DAP domain (including amino acid
E333) result in an inactive γ-secretase complex as as-
sessed by reconstitution assays in nicastrin-deficient
fibroblasts. If these mutations indeed inhibit γ-secre-
tase activity by preventing protein substrate recogni-
tion and not through a general effect on complex as-
sembly, then small soluble peptide substrates (that
conceivably can reach the catalytic site of presenilin by
diffusion) would still be cleaved by the mutated
γ-secretase complex. This prediction was experimen-
tally confirmed. Therefore, the conclusion that nicastrin
is needed for the recognition of γ-secretase substrates,
but not for their cleavage, is compelling.
Much work has shown that nicastrin is needed for
the correct assembly of the γ-secretase complex and
its movement to the cell surface. It is not unusual for
all partners of a protein complex to be correctly assem-
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Vmic reticulum. Apparently, the DAP domain of nicastrin
Pis not involved in assembly of the γ-secretase complex
Sbut, as Shah et al. (2005) confirm, the transmembrane
Sdomain of nicastrin is needed for the interaction of nic-
H
astrin with the other partners of the complex (Capell et 4
al., 2003; Morais et al., 2003). The new work defines
S
two clear functional domains in nicastrin: the DAP do-
Y
main for substrate recognition and the transmembrane A
domain for the assembly and correct trafficking of the t
γ-secretase complex to the cell surface.
DAlthough Shah et al. (2005) have solved an interesting
puzzle, many questions remain unanswered. For exam-
ple, what is the role of the two other γ-secretase com-
ponents aph-1 and pen-2? Several lines of research
suggest that presenilin has additional substrate binding
sites. Furthermore, two presenilin (and two aph-1)
genes exist in the human genome and thus at least four
different γ-secretase complexes can be generated. One
wonders whether presenilin or aph-1, in combination
with nicastrin, could confer some specificity on the
recognition of substrates (De Strooper, 2003). Finally,
when contemplating the γ-secretase machinery, one in-
fers that there must be active conformational changes
in the complex to push the transmembrane domain of
the protein substrate from the hydrophobic cell mem-
brane into the catalytic (probably water-containing)
pore of presenilin. Evidence that GTP or another energy
source is required for the cleavage activity of γ-secre-
tase has not yet been provided.
The experimental approaches and tools described by
Shah et al. (2005) reveal new ways to study γ-secretase
biochemistry in greater detail. It is particularly striking
how efficiently the active γ-secretase complex can be
produced in cells infected with baculovirus. One hopes
to see in the near future some real images of the com-
plex and more detailed biophysical studies of its activ-
ity. The next major challenge, a crystal structure of the
complex, will be much more difficult to achieve, given
the (estimated) 18 transmembrane domains of the core
γ-secretase complex. In any event, many exciting dis-
coveries remain to be made along the road to this ulti-
mate goal.
Bart De Strooper
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